Tissue engineered skin for diabetic foot ulcers: a meta-analysis.

about

The association between MCP-1, VEGF polymorphisms and their serum levels in patients with diabetic foot ulcer.

P2860

Q55405709-B69DFCC9-FBB1-4E7E-BB54-EFB0AC9E818C

P2860

Tissue engineered skin for diabetic foot ulcers: a meta-analysis.

Item

http://www.wikidata.org/entity/Q41572785

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Tissue engineered skin for diabetic foot ulcers: a meta-analysis.

@en

type

Item

label

Tissue engineered skin for diabetic foot ulcers: a meta-analysis.

@en

prefLabel

Tissue engineered skin for diabetic foot ulcers: a meta-analysis.

@en

P1476

Tissue engineered skin for diabetic foot ulcers: a meta-analysis.

@en

P2093

Geliang Xu

http://www.w3.org/2001/XMLSchema#string

Jianqiu Chen

http://www.w3.org/2001/XMLSchema#string

Xuedong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis.

Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis.

Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer.

Assessment and treatment of diabetic foot ulcer.

Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis.

Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.

HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.

Efficacy by ulcer type and safety of lipo-PGE1 for Japanese patients with diabetic foot ulcers.

A metabolically active human dermal replacement for the treatment of diabetic foot ulcers.

Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience.

P304

18191-18196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26770419

http://www.w3.org/2001/XMLSchema#string

P932

4694319

http://www.w3.org/2001/XMLSchema#string

Tissue engineered skin for diabetic foot ulcers: a meta-analysis.

about

P2860

P2860

Tissue engineered skin for diabetic foot ulcers: a meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932